Brief: Hansoh Pharmaceutical Announces Strategic Collaboration And License Agreement With Roche
Mon 11:15
BRIEF-Hansoh Pharmaceutical Announces Strategic Collaboration And License Agreement With Roche Oct 19 (Reuters) - Hansoh Pharmaceutical Group Company Limited 3692.HK:
STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH ROCHE
TO RECEIVE UPFRONT PAYMENT OF $400 MILLION AND FIRST ANNIVERSARY PAYMENT OF $110 MILLION
ELIGIBLE TO RECEIVE OVER $15 BILLION IN MILESTONE PAYMENTS AND TIERED ROYALTIES
RETAINS ALL RIGHTS TO PROGRAMS IN CHINESE MAINLAND, HONG KONG, MACAU AND TAIWAN
MAY SELECT UP TO TWO PROGRAMS FOR DEVELOPMENT OUTSIDE CHINESE MAINLAND, HONG KONG, MACAU AND TAIWAN
ON OCT 17, UNITS ENTERED STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH F. HOFFMANN-LA ROCHE
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roche Holding AG
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
Brief: Roche Says Sefaxersen Achieved Statistically Significant 43.1% Reduction In Proteinuria In Interim Phase III Data
Brief: Zymeworks Signs Exclusive Global Licensing Deal With Roche For Cancer Drug ZW209
Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal
DB ups Roche to 'buy' on positive oncology survey